Corvus Pharmaceuticals Inc. (CRVS) NASDAQ
$1.40 (0.01) (-0.71%)
Market Cap: $69.14M
As of 04/19/24 04:00 PM EDT. Market closed.
Corvus Pharmaceuticals Inc. (CRVS)
NASDAQ
$1.40
(0.01) (-0.71%)
Market Cap: $69.14M
As of 04/19/24 04:00 PM EDT. Market closed.
Add to Portfolio
corvus pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer. with accomplished and talented scientists, and top-tier investors, we are well positioned in an exciting new era of ... read more
corvus pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer. with accomplished and talented scientists, and top-tier investors, we are well positioned in an exciting new era of immuno-oncology. read less
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Richard Miller
Full Time Employees
36
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Richard Miller
Full Time Employees
36
CEO Compensation (Base)
$302,961
Address
863 Mitten Rd Ste 102, California, Burlingame, 94010-1311.
PRICE CHART FOR CORVUS PHARMACEUTICALS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$1.41
Previous Close
$1.41
Days Range
$1.36 - $1.44
52 week range
$0.98 - $4.19
Volume
58,804
Avg. Volume (30 days)
195,152
Market Cap
$69.14M
Dividend Yield
-
P/E
-
Shares Outstanding
49,038,582
Open
$1.41
Previous Close
$1.41
Days Range
$1.36 - $1.44
52 week range
$0.98 - $4.19
Volume
58,804
Avg. Volume (30 days)
195,152
Market Cap
$69.14M
Dividend Yield
-
P/E
-
Shares Outstanding
49,038,582
FINANCIAL STATEMENTS FOR CORVUS PHARMACEUTICALS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR CORVUS PHARMACEUTICALS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Grais Linda | Director | May 15, 2023 | Buy | $2.45 | 10,000 | 24,500 | 10,000 | May 16, 2023, 04:54 PM |
| Jones William Benton | See Remarks | Dec 20, 2022 | Buy | $0.79 | 20,000 | 15,800 | 133,773 | Dec 20, 2022, 06:22 PM |
| LEA LEIV | Chief Financial Officer | Dec 14, 2022 | Buy | $0.84 | 4,000 | 3,364 | 133,238 | Dec 15, 2022, 04:33 PM |
| LEA LEIV | Chief Financial Officer | Dec 13, 2022 | Buy | $0.74 | 30,000 | 22,275 | 129,238 | Dec 15, 2022, 04:33 PM |
| MILLER RICHARD A MD | President and CEO | Dec 14, 2022 | Buy | $0.78 | 10,000 | 7,812 | 1,490,119 | Dec 15, 2022, 04:32 PM |
| MILLER RICHARD A MD | President and CEO | Dec 13, 2022 | Buy | $0.74 | 50,000 | 37,015 | 1,480,119 | Dec 15, 2022, 04:32 PM |
| MILLER RICHARD A MD | President and CEO | Sep 28, 2022 | Buy | $0.76 | 25,000 | 19,070 | 1,394,405 | Sep 28, 2022, 05:45 PM |
| MILLER RICHARD A MD | President and CEO | Sep 20, 2022 | Buy | $0.81 | 20,000 | 16,253 | 1,369,405 | Sep 20, 2022, 06:58 PM |
| MILLER RICHARD A MD | President and CEO | Jun 27, 2022 | Buy | $1.00 | 5,000 | 4,985 | 1,349,405 | Jun 28, 2022, 07:15 PM |
| MILLER RICHARD A MD | President and CEO | Jun 24, 2022 | Buy | $1.03 | 5,000 | 5,150 | 1,344,405 | Jun 28, 2022, 07:15 PM |
| MILLER RICHARD A MD | President and CEO | Jun 06, 2022 | Buy | $1.01 | 890 | 899 | 1,339,405 | Jun 06, 2022, 06:43 PM |
| MILLER RICHARD A MD | President and CEO | Jun 02, 2022 | Buy | $0.98 | 5,000 | 4,898 | 1,338,515 | Jun 06, 2022, 06:43 PM |
| MILLER RICHARD A MD | President and CEO | Mar 31, 2022 | Buy | $1.64 | 15,000 | 24,534 | 1,333,515 | Apr 01, 2022, 04:18 PM |
| LEA LEIV | Chief Financial Officer | Mar 16, 2022 | Buy | $1.54 | 35,160 | 54,146 | 85,360 | Mar 17, 2022, 07:10 PM |
| LEA LEIV | Chief Financial Officer | Mar 17, 2022 | Buy | $1.65 | 13,878 | 22,899 | 99,238 | Mar 17, 2022, 07:10 PM |
| MILLER RICHARD A MD | President and CEO | Mar 17, 2022 | Buy | $1.59 | 5,000 | 7,950 | 1,318,515 | Mar 17, 2022, 07:09 PM |
| MILLER RICHARD A MD | President and CEO | Mar 15, 2022 | Buy | $1.47 | 25,000 | 36,650 | 1,313,515 | Mar 17, 2022, 07:09 PM |
| EcoR1 Capital, LLC | 10% Owner | Oct 01, 2021 | Sale | $4.96 | 2,000,000 | 9,928,800 | 81,077 | Oct 01, 2021, 07:39 PM |
| EcoR1 Capital, LLC | 10% Owner | Sep 30, 2021 | Sale | $5.04 | 3,000,000 | 15,131,101 | 2,081,077 | Oct 01, 2021, 07:39 PM |
| ORBIMED ADVISORS LLC | Director | Sep 20, 2021 | Sale | $6.09 | 1,109,644 | 6,757,732 | 6,943,654 | Sep 22, 2021, 05:27 PM |
| Thompson Peter A. | Director | Sep 20, 2021 | Sale | $6.09 | 1,109,644 | 6,757,732 | 6,943,654 | Sep 22, 2021, 05:24 PM |
| MILLER RICHARD A MD | President and CEO | Aug 20, 2021 | Buy | $1.93 | 10,000 | 19,254 | 1,288,515 | Aug 23, 2021, 09:01 PM |
| ORBIMED ADVISORS LLC | Director | Feb 17, 2021 | Buy | $3.50 | 1,285,714 | 4,499,999 | 8,053,298 | Feb 19, 2021, 04:52 PM |
| Thompson Peter A. | Director | Feb 17, 2021 | Buy | $3.50 | 1,285,714 | 4,499,999 | 8,053,298 | Feb 19, 2021, 04:47 PM |
| MILLER RICHARD A MD | President and CEO | Feb 17, 2021 | Buy | $3.50 | 100,000 | 350,000 | 1,278,515 | Feb 17, 2021, 04:44 PM |
| Novo Holdings A/S | 10% Owner | Jul 07, 2020 | Sale | $5.25 | 796,622 | 4,183,381 | 2,130,938 | Jul 09, 2020, 04:35 PM |
| Novo Holdings A/S | 10% Owner | Jul 08, 2020 | Sale | $5.37 | 741,440 | 3,985,166 | 1,389,498 | Jul 09, 2020, 04:35 PM |
| MILLER RICHARD A MD | President and CEO | Nov 13, 2019 | Buy | $3.00 | 14,736 | 44,240 | 1,178,515 | Nov 14, 2019, 04:14 PM |
| MILLER RICHARD A MD | President and CEO | Nov 12, 2019 | Buy | $2.90 | 272 | 789 | 1,163,779 | Nov 14, 2019, 04:14 PM |
| Thompson Peter A. | Director | Aug 06, 2019 | Buy | $3.51 | 142,656 | 500,723 | 6,767,584 | Aug 08, 2019, 05:00 PM |
| ORBIMED ADVISORS LLC | Director | Aug 06, 2019 | Buy | $3.51 | 142,656 | 500,723 | 6,767,584 | Aug 08, 2019, 04:59 PM |
| MILLER RICHARD A MD | President and CEO | Aug 07, 2019 | Buy | $3.54 | 2,500 | 8,850 | 1,163,507 | Aug 08, 2019, 04:07 PM |
| MILLER RICHARD A MD | President and CEO | Aug 06, 2019 | Buy | $3.58 | 5,000 | 17,875 | 1,161,007 | Aug 08, 2019, 04:07 PM |
| Novo Holdings A/S | 10% Owner | Jul 25, 2019 | Sale | $4.00 | 1,400,000 | 5,600,000 | 2,927,560 | Jul 25, 2019, 07:21 PM |
| Novo Holdings A/S | 10% Owner | Jul 24, 2019 | Sale | $5.01 | 53,240 | 266,711 | 4,327,560 | Jul 25, 2019, 07:21 PM |
| Novo Holdings A/S | 10% Owner | Jul 23, 2019 | Sale | $5.32 | 39,716 | 211,134 | 4,380,800 | Jul 25, 2019, 07:21 PM |
| Thompson Peter A. | Director | Jun 28, 2019 | Buy | $3.72 | 565,178 | 2,102,462 | 6,565,685 | Jul 01, 2019, 06:16 PM |
| Thompson Peter A. | Director | Jun 27, 2019 | Buy | $3.34 | 32,923 | 109,963 | 6,000,507 | Jul 01, 2019, 06:16 PM |
| Thompson Peter A. | Director | Jul 01, 2019 | Buy | $3.91 | 59,243 | 231,640 | 6,624,928 | Jul 01, 2019, 06:16 PM |
| ORBIMED ADVISORS LLC | Director | Jul 01, 2019 | Buy | $3.91 | 59,243 | 231,640 | 6,624,928 | Jul 01, 2019, 06:15 PM |
| ORBIMED ADVISORS LLC | Director | Jun 28, 2019 | Buy | $3.72 | 565,178 | 2,102,462 | 6,565,685 | Jul 01, 2019, 06:15 PM |
| ORBIMED ADVISORS LLC | Director | Jun 27, 2019 | Buy | $3.34 | 32,923 | 109,963 | 6,000,507 | Jul 01, 2019, 06:15 PM |
| MILLER RICHARD A MD | President and CEO | Jun 14, 2019 | Buy | $3.40 | 11,657 | 39,666 | 1,156,007 | Jun 17, 2019, 04:08 PM |
| MILLER RICHARD A MD | President and CEO | Jun 13, 2019 | Buy | $3.52 | 343 | 1,207 | 1,144,350 | Jun 17, 2019, 04:08 PM |
| MILLER RICHARD A MD | President and CEO | Jun 11, 2019 | Buy | $3.67 | 6,000 | 22,020 | 1,144,007 | Jun 11, 2019, 04:55 PM |
| MILLER RICHARD A MD | President and CEO | Jun 07, 2019 | Buy | $3.37 | 9,212 | 31,019 | 1,138,007 | Jun 11, 2019, 04:55 PM |
| LEA LEIV | Chief Financial Officer | Jun 07, 2019 | Buy | $3.38 | 10,000 | 33,800 | 50,200 | Jun 10, 2019, 04:12 PM |
| LEA LEIV | Chief Financial Officer | Jun 06, 2019 | Buy | $3.56 | 15,500 | 55,180 | 40,200 | Jun 10, 2019, 04:12 PM |
| MILLER RICHARD A MD | President and CEO | Dec 27, 2018 | Buy | $3.29 | 20,000 | 65,884 | 1,128,795 | Dec 31, 2018, 04:16 PM |
| LEA LEIV | Chief Financial Officer | Dec 21, 2018 | Buy | $4.15 | 24,700 | 102,409 | 24,700 | Dec 27, 2018, 04:08 PM |
| MILLER RICHARD A MD | President and CEO | Dec 20, 2018 | Buy | $4.39 | 10,000 | 43,950 | 1,108,795 | Dec 26, 2018, 04:05 PM |
| MILLER RICHARD A MD | President and CEO | Dec 06, 2018 | Buy | $5.99 | 5,000 | 29,934 | 1,118,795 | Dec 10, 2018, 04:05 PM |
| MILLER RICHARD A MD | President and CEO | Dec 04, 2018 | Buy | $5.95 | 1,502 | 8,937 | 1,113,795 | Dec 06, 2018, 04:06 PM |
| Thompson Peter A. | Director | Mar 12, 2018 | Buy | $8.50 | 588,235 | 4,999,998 | 5,967,584 | Mar 14, 2018, 02:05 PM |
| ORBIMED ADVISORS LLC | Director | Mar 12, 2018 | Buy | $8.50 | 588,235 | 4,999,998 | 5,967,584 | Mar 14, 2018, 01:58 PM |
| Novo Holdings A/S | 10% Owner | Mar 12, 2018 | Buy | $8.50 | 1,176,470 | 9,999,995 | 4,420,516 | Mar 13, 2018, 05:12 PM |
| Gould Terry P | Director | Mar 12, 2018 | Buy | $8.50 | 588,235 | 4,999,998 | 236,128 | Mar 13, 2018, 04:07 PM |
| ADAMS STREET PARTNERS LLC | 10% Owner | Mar 12, 2018 | Buy | $8.50 | 588,235 | 4,999,998 | 236,128 | Mar 13, 2018, 03:30 PM |
| MILLER RICHARD A MD | President and CEO | Mar 12, 2018 | Buy | $8.50 | 100,000 | 850,000 | 1,112,293 | Mar 12, 2018, 04:05 PM |
| MILLER RICHARD A MD | President and CEO | Nov 20, 2017 | Buy | $10.78 | 10,000 | 107,850 | 1,012,293 | Nov 22, 2017, 04:06 PM |
| Novo Holdings A/S | 10% Owner | Jun 23, 2017 | Buy | $10.95 | 20,000 | 219,000 | 3,244,046 | Jun 27, 2017, 04:52 PM |
| MILLER RICHARD A MD | President and CEO | Jun 13, 2017 | Buy | $9.95 | 5,000 | 49,725 | 1,002,293 | Jun 13, 2017, 04:06 PM |
| MILLER RICHARD A MD | President and CEO | Jun 12, 2017 | Buy | $9.82 | 11,216 | 110,185 | 997,293 | Jun 13, 2017, 04:06 PM |
| MILLER RICHARD A MD | President and CEO | Jun 09, 2017 | Buy | $9.92 | 8,784 | 87,174 | 986,077 | Jun 13, 2017, 04:06 PM |
| Thompson Peter A. | Director | Jun 23, 2016 | Buy | $12.92 | 100 | 1,292 | 5,378,449 | Jun 27, 2016, 06:51 PM |
| Thompson Peter A. | Director | Jun 24, 2016 | Buy | $12.99 | 900 | 11,691 | 5,379,349 | Jun 27, 2016, 06:51 PM |
| ORBIMED ADVISORS LLC | Director | Jun 24, 2016 | Buy | $12.99 | 900 | 11,691 | 5,379,349 | Jun 27, 2016, 06:47 PM |
| ORBIMED ADVISORS LLC | Director | Jun 23, 2016 | Buy | $12.92 | 100 | 1,292 | 5,378,449 | Jun 27, 2016, 06:47 PM |
| Thompson Peter A. | Director | Jun 21, 2016 | Buy | $12.87 | 26,083 | 335,688 | 5,378,349 | Jun 21, 2016, 07:00 PM |
| Thompson Peter A. | Director | Jun 17, 2016 | Buy | $12.48 | 12,300 | 153,504 | 5,352,266 | Jun 21, 2016, 07:00 PM |
| ORBIMED ADVISORS LLC | Director | Jun 21, 2016 | Buy | $12.87 | 26,083 | 335,688 | 5,378,349 | Jun 21, 2016, 06:55 PM |
| ORBIMED ADVISORS LLC | Director | Jun 17, 2016 | Buy | $12.48 | 12,300 | 153,504 | 5,352,266 | Jun 21, 2016, 06:55 PM |
| Thompson Peter A. | Director | Jun 16, 2016 | Buy | $12.04 | 5,000 | 60,200 | 5,339,966 | Jun 16, 2016, 06:05 PM |
| Thompson Peter A. | Director | Jun 15, 2016 | Buy | $11.94 | 5,000 | 59,700 | 5,334,966 | Jun 16, 2016, 06:05 PM |
| Thompson Peter A. | Director | Jun 14, 2016 | Buy | $12.71 | 10,000 | 127,100 | 5,329,966 | Jun 16, 2016, 06:05 PM |
| ORBIMED ADVISORS LLC | Director | Jun 16, 2016 | Buy | $12.04 | 5,000 | 60,200 | 5,339,966 | Jun 16, 2016, 05:59 PM |
| ORBIMED ADVISORS LLC | Director | Jun 15, 2016 | Buy | $11.94 | 5,000 | 59,700 | 5,334,966 | Jun 16, 2016, 05:59 PM |
| ORBIMED ADVISORS LLC | Director | Jun 14, 2016 | Buy | $12.71 | 10,000 | 127,100 | 5,329,966 | Jun 16, 2016, 05:59 PM |
| Thompson Peter A. | Director | Jun 10, 2016 | Buy | $12.98 | 20,000 | 259,600 | 5,319,966 | Jun 13, 2016, 05:23 PM |
| Thompson Peter A. | Director | Jun 09, 2016 | Buy | $12.95 | 30,000 | 388,500 | 5,299,966 | Jun 13, 2016, 05:23 PM |
| ORBIMED ADVISORS LLC | Director | Jun 10, 2016 | Buy | $12.98 | 20,000 | 259,600 | 5,319,966 | Jun 13, 2016, 05:18 PM |
| ORBIMED ADVISORS LLC | Director | Jun 09, 2016 | Buy | $12.95 | 30,000 | 388,500 | 5,299,966 | Jun 13, 2016, 05:18 PM |
| Thompson Peter A. | Director | May 20, 2016 | Buy | $13.09 | 4,716 | 61,732 | 5,269,966 | May 24, 2016, 04:48 PM |
| ORBIMED ADVISORS LLC | Director | May 20, 2016 | Buy | $13.09 | 4,716 | 61,732 | 5,269,966 | May 24, 2016, 04:37 PM |
| ORBIMED ADVISORS LLC | Director | May 19, 2016 | Buy | $12.13 | 2,600 | 31,525 | 5,265,250 | May 20, 2016, 05:21 PM |
| ORBIMED ADVISORS LLC | Director | May 18, 2016 | Buy | $11.55 | 4,200 | 48,510 | 5,262,650 | May 20, 2016, 05:21 PM |
| Thompson Peter A. | Director | May 19, 2016 | Buy | $12.13 | 2,600 | 31,525 | 5,265,250 | May 20, 2016, 04:27 PM |
| Thompson Peter A. | Director | May 18, 2016 | Buy | $11.55 | 4,200 | 48,510 | 5,262,650 | May 20, 2016, 04:27 PM |
| MILLER RICHARD A MD | President and CEO | May 13, 2016 | Buy | $9.94 | 300 | 2,981 | 1,077,293 | May 16, 2016, 06:38 PM |
| MILLER RICHARD A MD | President and CEO | May 12, 2016 | Buy | $10.00 | 30,000 | 300,000 | 1,076,993 | May 16, 2016, 06:38 PM |
| Novo A/S | 10% Owner | May 12, 2016 | Buy | $10.00 | 70,000 | 700,000 | 3,224,046 | May 16, 2016, 05:01 PM |
| Novo A/S | 10% Owner | Mar 29, 2016 | Buy | $15.00 | 666,666 | 9,999,990 | 3,154,046 | Mar 30, 2016, 01:07 PM |
| ORBIMED ADVISORS LLC | Director | Mar 29, 2016 | Buy | $15.00 | 550,000 | 8,250,000 | 5,258,450 | Mar 29, 2016, 12:21 PM |
| Thompson Peter A. | Director | Mar 29, 2016 | Buy | $15.00 | 550,000 | 8,250,000 | 5,258,450 | Mar 29, 2016, 12:00 PM |
| ADAMS STREET PARTNERS LLC | 10% Owner | Mar 29, 2016 | Buy | $15.00 | 200,000 | 3,000,000 | 736,033 | Mar 29, 2016, 11:54 AM |
| Gould Terry P | Director | Mar 29, 2016 | Buy | $15.00 | 200,000 | 3,000,000 | 736,033 | Mar 29, 2016, 11:39 AM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Load More Insider Transactions
FUNDS WITH A POSITION IN CORVUS PHARMACEUTICALS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 6,943,654 | 0.24% | No change | Other |
| RENAISSANCE TECHNOLOGIES LLC | 587,432 | 0.0016% | 39.29% | Other |
| BLACKROCK INC. | 520,551 | 0.00002% | -0.13% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 360,380 | 0.00007% | No change | Other |
CHANGE IN SHARES OUTSTANDING FOR CORVUS PHARMACEUTICALS INC
STOCK BUYBACKS FOR CORVUS PHARMACEUTICALS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.16%
1Q
06/30/2023
3.27%
2Q
03/31/2023
5.36%
3Q
12/31/2022
5.36%
4Q
09/30/2022
5.36%
5Q
06/30/2022
5.36%
6Q
03/31/2022
5.36%
7Q
12/31/2021
5.25%
8Q
09/30/2021
11.61%
9Q
06/30/2021
16.10%
10Q
03/31/2021
42.11%
11Q
12/31/2020
65.39%
12Q
09/30/2020
66.27%
13Q
06/30/2020
66.68%
14Q
03/31/2020
66.77%
15Q
12/31/2019
66.81%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR CORVUS PHARMACEUTICALS INC
LOADING...